For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250610:nRSJ2668Ma&default-theme=true
RNS Number : 2668M Animalcare Group PLC 10 June 2025
Animalcare Group plc
(''Animalcare'', "the Company" or "the Group")
Result of 2025 AGM
10 June 2025. Animalcare Group plc confirms that all the resolutions put to
the Annual General Meeting ("AGM") today were duly passed. All resolutions
were decided on a poll. Resolutions 1 to 12 were passed as ordinary
resolutions and resolutions 13 to 15 were passed as special resolutions. The
voting results are given below.
No. Resolution Votes FOR (including discretionary) % Votes AGAINST % % of ISC Voted Votes WITHHELD
1 To receive the audited annual accounts of the Company for the year ended 31 53,220,613 99.99 3,770 0.01 77.15 0
December 2024 together with the directors' report and the auditors' report on
those annual accounts.
2 To declare a final dividend for the year ended 31 December 2024 of 3.0 pence 53,224,137 99.99 246 0.01 77.15 0
per ordinary share.
3 To re-elect Mr C Brewster as a Director. 52,708,839 99.95 24,176 0.05 76.44 491,368
4 To re-elect Mr M Coucke as a Director. 53,186,483 99.95 24,176 0.05 77.13 13,724
5 To re-elect Mr D Hutchens as a Director. 48,896,136 91.88 4,318,794 8.12 77.14 9,453
6 To re-elect Ms S Metayer as a Director. 53,214,680 99.99 250 0.01 77.14 9,453
7 To re-elect Mr E Torr as a Director. 53,211,156 99.99 3,774 0.01 77.14 9,453
8 To re-elect Ms J Winter as a Director 53,190,754 99.95 24,176 0.05 77.14 9,453
9 To approve the Directors' Remuneration Report as set out in the Annual Report 52,729,822 99.09 482,161 0.91 77.13 12,400
and Accounts 2024.
10 To approve the re-appointment of Grant Thornton UK LLP as auditors of the 53,220,613 99.99 3,770 0.01 77.15 0
Company.
11 To authorise the Audit and Risk Committee to determine the remuneration of the 53,211,160 99.99 3,770 0.01 77.14 9,453
auditors.
12 To authorise the Directors to allot shares. 48,971,758 92.01 4,250,425 7.99 77.15 2,200
13 To authorise the Directors to disapply statutory pre-emption rights in respect 48,445,437 91.06 4,754,246 8.94 77.11 24,700
of the Company's issued share capital.
14 To authorise the Directors to disapply pre-emption rights for purposes of 48,467,937 91.07 4,754,246 8.93 77.15 2,200
acquisitions or capital investments.
15 To authorise the Company to purchase its own shares. 51,794,306 99.99 3,946 0.01 75.08 1,426,131
Notes:
1. Any proxy arrangement which gave discretion to the Chairman has been
included in the "For" totals.
2. A "Vote withheld" is not a vote in law and is not counted in the
calculation of the percentage of shares voted "For" or "Against" any
resolution.
3. The number of shares in issue at 9.30am on 6 June 2025 was 68,989,072
("ISC"). Holders of ordinary shares are entitled to one vote per share. No
shares are held in treasury.
Animalcare Group Plc +44 (0)1904 487 687
Jennifer Winter, Chief Executive Officer
Chris Brewster, Chief Financial Officer communications@animalcaregroup.com
Media/investor relations
Stifel +44 (0)20 7710 7600
(Nominated Advisor & Joint Broker)
Ben Maddison
Nicholas Harland
Francis North
Panmure Liberum +44 (0)20 7886 2500
(Joint Broker)
Corporate Finance
Freddy Crossley/Emma Earl
Corporate Banking
Rupert Dearden
Alma Strategic Communications +44 (0)20 3405 0205
Caroline Forde animalcare@almastrategic.com
Kinvara Verdon
Rose Docherty
For more information, please visit www.animalcaregroup.com
(http://www.animalcaregroup.com) or contact:
About Animalcare
Animalcare Group plc is a UK AIM-listed international veterinary sales and
marketing organisation. Animalcare operates in seven European countries as
well as Australia and New Zealand and exports to approximately 40 countries
worldwide. The Group is focused on bringing new and innovative products to
market through its own development pipeline, partnerships and via acquisition.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END RAGGPUWWQUPAGAU